Hanna SK - Search Results

1

Effect of radiation on the penetration of irinotecan in rat cerebrospinal fluid.

Khatri A, Gaber MW, Brundage RC, Naimark MD, Hanna SK, Stewart CF, Kirstein MN. Khatri A, et al. Among authors: hanna sk. Cancer Chemother Pharmacol. 2011 Sep;68(3):721-31. doi: 10.1007/s00280-010-1542-3. Epub 2010 Dec 16. Cancer Chemother Pharmacol. 2011. PMID: 21161529

2

The importance of tumor glucuronidase in the activation of irinotecan in a mouse xenograft model.

Dodds HM, Tobin PJ, Stewart CF, Cheshire P, Hanna S, Houghton P, Rivory LP. Dodds HM, et al. J Pharmacol Exp Ther. 2002 Nov;303(2):649-55. doi: 10.1124/jpet.102.039040. J Pharmacol Exp Ther. 2002. PMID: 12388647

3

Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.

Zamboni WC, Houghton PJ, Hulstein JL, Kirstein M, Walsh J, Cheshire PJ, Hanna SK, Danks MK, Stewart CF. Zamboni WC, et al. Among authors: hanna sk. Cancer Chemother Pharmacol. 1999;43(4):269-76. doi: 10.1007/s002800050894. Cancer Chemother Pharmacol. 1999. PMID: 10071976

4

Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.

Zamboni WC, Houghton PJ, Thompson J, Cheshire PJ, Hanna SK, Richmond LB, Lou X, Stewart CF. Zamboni WC, et al. Among authors: hanna sk. Clin Cancer Res. 1998 Feb;4(2):455-62. Clin Cancer Res. 1998. PMID: 9516936

5

Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan.

Ma MK, Zamboni WC, Radomski KM, Furman WL, Santana VM, Houghton PJ, Hanna SK, Smith AK, Stewart CF. Ma MK, et al. Among authors: hanna sk. Clin Cancer Res. 2000 Mar;6(3):813-9. Clin Cancer Res. 2000. PMID: 10741701 Clinical Trial.

6

Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts.

Kirstein MN, Houghton PJ, Cheshire PJ, Richmond LB, Smith AK, Hanna SK, Stewart CF. Kirstein MN, et al. Among authors: hanna sk. Clin Cancer Res. 2001 Feb;7(2):358-66. Clin Cancer Res. 2001. PMID: 11234891

7

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.

Zamboni WC, Stewart CF, Cheshire PJ, Richmond LB, Hanna SK, Luo X, Poquette C, McGovren JP, Houghton JA, Houghton PJ. Zamboni WC, et al. Among authors: hanna sk. Clin Cancer Res. 1998 Mar;4(3):743-53. Clin Cancer Res. 1998. PMID: 9533544

8

Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detection.

Bai F, Kirstein MN, Hanna SK, Iacono LC, Johnston B, Stewart CF. Bai F, et al. Among authors: hanna sk. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 5;784(2):225-32. doi: 10.1016/s1570-0232(02)00798-5. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12505770

9

New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065.

Bai F, Kirstein MN, Hanna SK, Stewart CF. Bai F, et al. Among authors: hanna sk. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):257-65. doi: 10.1016/s1570-0232(02)00104-6. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12007770

10

Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretion.

Zamboni WC, Houghton PJ, Johnson RK, Hulstein JL, Crom WR, Cheshire PJ, Hanna SK, Richmond LB, Luo X, Stewart CF. Zamboni WC, et al. Among authors: hanna sk. J Pharmacol Exp Ther. 1998 Jan;284(1):89-94. J Pharmacol Exp Ther. 1998. PMID: 9435165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters